Roland Dunbrack
Inventor
Stats
- 3 US patents issued
- 7 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 7 US Applications Filed
- 52 Total Citation Count
- Apr 24, 2020 Most Recent Filing
- Feb 7, 2007 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
PHYLOGICA LIMITED | 2
2 1 | 2007
2013 2016 |
FOX CHASE CANCER CENTER | 1
1 2 | 2010
2011 2012 |
Inventor Addresses
Address | Duration |
---|---|
Philadelphia, PA | Apr 03, 08 - Apr 03, 08 |
Philadelphia, PA, US | May 03, 12 - Sep 15, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
C07K: | PEPTIDES | 6 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2022/0289,823 | 2022 | Netrin G1 And Netrin G1 Ligand Peptides And Antibodies And Uses Thereof | 0 |
2017/0183,374 | 2017 | Methods of Constructing and Screening Libraries of Peptide Structures | 0 |
9611321 | 2017 | Rationally-designed anti-mullerian inhibiting substance type II receptor antibodies | 0 |
9567373 | 2017 | Methods of constructing and screening libraries of peptide structures | 1 |
2014/0234,213 | 2014 | Rationally-Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.